Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Rebecca M. Reese, Kyle T. Helzer, Kaelyn O. Allen, Christy Zheng, Natalia Solodin & Elaine T. Alarid. (2022) GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and Repression. Molecular and Cellular Biology 42:10.
Read now
Read now
Kyle T. Helzer, Mary Szatkowski Ozers, Mark B. Meyer, Nancy A. Benkusky, Natalia Solodin, Rebecca M. Reese, Christopher L. Warren, J. Wesley Pike & Elaine T. Alarid. (2019) The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2. Molecular and Cellular Biology 39:3.
Read now
Read now
Prashant Rajbhandari, Greg Finn, Natalia M. Solodin, Kiran K. Singarapu, Sarata C. Sahu, John L. Markley, Kelley J. Kadunc, Stephanie J. Ellison-Zelski, Anastasia Kariagina, Sandra Z. Haslam, Kun Ping Lu & Elaine T. Alarid. (2012) Regulation of Estrogen Receptor α N-Terminus Conformation and Function by Peptidyl Prolyl Isomerase Pin1. Molecular and Cellular Biology 32:2, pages 445-457.
Read now
Read now
Sukesh R. Bhaumik & Shivani Malik. (2008) Diverse Regulatory Mechanisms of Eukaryotic Transcriptional Activation by the Proteasome Complex. Critical Reviews in Biochemistry and Molecular Biology 43:6, pages 419-433.
Read now
Read now
Yukiyo Tateishi, Raku Sonoo, Yu-ichi Sekiya, Nanae Sunahara, Miwako Kawano, Mitsutoshi Wayama, Ryuichi Hirota, Yoh-ichi Kawabe, Akiko Murayama, Shigeaki Kato, Keiji Kimura & Junn Yanagisawa. (2006) Turning Off Estrogen Receptor β-Mediated Transcription Requires Estrogen-Dependent Receptor Proteolysis. Molecular and Cellular Biology 26:21, pages 7966-7976.
Read now
Read now
Articles from other publishers (75)
Eric B. Wright & Deborah A. Lannigan. (2022) ERK1/2‐RSK regulation of oestrogen homeostasis. The FEBS Journal 290:8, pages 1943-1953.
Crossref
Crossref
Angeles C. Tecalco-Cruz, Lilia López-Canovas & Elisa Azuara-Liceaga. (2023) Estrogen signaling via estrogen receptor alpha and its implications for neurodegeneration associated with Alzheimer’s disease in aging women. Metabolic Brain Disease 38:3, pages 783-793.
Crossref
Crossref
Arvind Negi, Kavindra Kumar Kesari & Anne Sophie Voisin-Chiret. (2022) Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs. Pharmaceutics 14:11, pages 2523.
Crossref
Crossref
Nina E. Baumgartner, Shannon M. McQuillen, Samantha F. Perry, Sangtawan Miller, Matthieu J. Maroteaux, Robert B. Gibbs & Jill M. Daniel. (2022) History of Previous Midlife Estradiol Treatment Permanently Alters Interactions of Brain Insulin-like Growth Factor-1 Signaling and Hippocampal Estrogen Synthesis to Enhance Cognitive Aging in a Rat Model of Menopause. The Journal of Neuroscience 42:42, pages 7969-7983.
Crossref
Crossref
Mostafa A. Aboouf, Julia Armbruster, Markus Thiersch, Franco Guscetti, Glen Kristiansen, Peter Schraml, Anne Bicker, Ruben Petry, Thomas Hankeln, Max Gassmann & Thomas A. Gorr. (2022) Pro-Apoptotic and Anti-Invasive Properties Underscore the Tumor-Suppressing Impact of Myoglobin on a Subset of Human Breast Cancer Cells. International Journal of Molecular Sciences 23:19, pages 11483.
Crossref
Crossref
Houng-Wei Tsai, Vicky Y. Lin & Margaret A. Shupnik. (2022) Forskolin Stimulates Estrogen Receptor (ER) α Transcriptional Activity and Protects ER from Degradation by Distinct Mechanisms. International Journal of Endocrinology 2022, pages 1-17.
Crossref
Crossref
Marine Adlanmerini, Coralie Fontaine, Pierre Gourdy, Jean-François Arnal & Françoise Lenfant. (2022) Segregation of nuclear and membrane-initiated actions of estrogen receptor using genetically modified animals and pharmacological tools. Molecular and Cellular Endocrinology 539, pages 111467.
Crossref
Crossref
Sarah A. Jeffreys, Branka Powter, Bavanthi Balakrishnar, Kelly Mok, Patsy Soon, André Franken, Hans Neubauer, Paul de Souza & Therese M. Becker. (2020) Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability. Cells 9:9, pages 2077.
Crossref
Crossref
Sreeja Sreekumar, Kevin M Levine, Matthew J Sikora, Jian Chen, Nilgun Tasdemir, Dorothy Carter, David J Dabbs, Carolin Meier, Ahmed Basudan, David Boone, Priscilla F McAuliffe, Rachel C Jankowitz, Adrian V Lee, Jennifer M Atkinson & Steffi Oesterreich. (2020) Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma. Endocrinology 161:9.
Crossref
Crossref
Georgina P. Sava, Hailing Fan, R. Charles Coombes, Lakjaya Buluwela & Simak Ali. (2020) CDK7 inhibitors as anticancer drugs. Cancer and Metastasis Reviews 39:3, pages 805-823.
Crossref
Crossref
Katarzyna A. Ludwik, Zachary M. Sandusky, Kimberly M. Stauffer, Yu Li, Kelli L. Boyd, George A. O’Doherty, Thomas P. Stricker & Deborah A. Lannigan. (2020) RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha. Cell Reports 32:3, pages 107931.
Crossref
Crossref
Jie Yu, Sarah L Berga, Wei Zou & Robert N Taylor. (2019) Interleukin-1β inhibits estrogen receptor-α, progesterone receptors A and B and biomarkers of human endometrial stromal cell differentiation: implications for endometriosis. Molecular Human Reproduction 25:10, pages 625-637.
Crossref
Crossref
Genevieve V Dall, Samuel Hawthorne, Yashar Seyed-Razavi, Jessica Vieusseux, Wanfu Wu, Jan-Ake Gustafsson, David Byrne, Leigh Murphy, Gail P Risbridger & Kara L Britt. (2018) Estrogen receptor subtypes dictate the proliferative nature of the mammary gland. Journal of Endocrinology 237:3, pages 323-336.
Crossref
Crossref
Hetal Patel, Manikandan Periyasamy, Georgina P. Sava, Alexander Bondke, Brian W. Slafer, Sebastian H. B. Kroll, Marion Barbazanges, Richard Starkey, Silvia Ottaviani, Alison Harrod, Eric O. Aboagye, Laki Buluwela, Matthew J. Fuchter, Anthony G. M. Barrett, R. Charles Coombes & Simak Ali. (2018) ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment. Molecular Cancer Therapeutics 17:6, pages 1156-1166.
Crossref
Crossref
Sara Sannino & Jeffrey L. Brodsky. (2017) Targeting protein quality control pathways in breast cancer. BMC Biology 15:1.
Crossref
Crossref
A Harrod, J Fulton, V T M Nguyen, M Periyasamy, L Ramos-Garcia, C-F Lai, G Metodieva, A de Giorgio, R L Williams, D B Santos, P J Gomez, M-L Lin, M V Metodiev, J Stebbing, L Castellano, L Magnani, R C Coombes, L Buluwela & S Ali. (2016) Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer. Oncogene 36:16, pages 2286-2296.
Crossref
Crossref
Hetal Patel, Rezvan Abduljabbar, Chun-Fui Lai, Manikandan Periyasamy, Alison Harrod, Carolina Gemma, Jennifer H. Steel, Naina Patel, Claudia Busonero, Dena Jerjees, Judit Remenyi, Sally Smith, Jennifer J. Gomm, Luca Magnani, Balázs Győrffy, Louise J. Jones, Frances Fuller-Pace, Sami Shousha, Laki Buluwela, Emad A. Rakha, Ian O. Ellis, R. Charles Coombes & Simak Ali. (2016) Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor–Positive Breast Cancer. Clinical Cancer Research 22:23, pages 5929-5938.
Crossref
Crossref
K. L. Black, C. F. Witty & J. M. Daniel. (2016) Previous Midlife Oestradiol Treatment Results in Long-Term Maintenance of Hippocampal Oestrogen Receptor α Levels in Ovariectomised Rats: Mechanisms and Implications for Memory. Journal of Neuroendocrinology 28:10.
Crossref
Crossref
Watanyoo Nakareangrit, Apinya Thiantanawat, Daranee Visitnonthachai, Piyajit Watcharasit & Jutamaad Satayavivad. (2016) Sodium arsenite inhibited genomic estrogen signaling but induced pERα (Ser118) via MAPK pathway in breast cancer cells. Environmental Toxicology 31:9, pages 1133-1146.
Crossref
Crossref
Wendy M. Swetzig, Jianmin Wang & Gokul M. Das. (2016) Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer. Oncotarget 7:13, pages 16049-16069.
Crossref
Crossref
Angelo J. Casa, Daniel Hochbaum, Sreeja Sreekumar, Steffi Oesterreich & Adrian V. Lee. (2015) The estrogen receptor alpha nuclear localization sequence is critical for fulvestrant-induced degradation of the receptor. Molecular and Cellular Endocrinology 415, pages 76-86.
Crossref
Crossref
Elisa Baldelli, Guido Bellezza, Eric B. Haura, Lucio Crinó, W. Douglas Cress, Jianghong Deng, Vienna Ludovini, Angelo Sidoni, Matthew B. Schabath, Francesco Puma, Jacopo Vannucci, Annamaria Siggillino, Lance A. Liotta, Emanuel F. PetricoinIIIIII & Mariaelena Pierobon. (2015)
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for
KRAS
mutant tumors
. Oncotarget 6:32, pages 32368-32379.
Crossref
Crossref
Kyle T Helzer, Christopher Hooper, Shigeki Miyamoto & Elaine T Alarid. (2015) Ubiquitylation of nuclear receptors: new linkages and therapeutic implications. Journal of Molecular Endocrinology 54:3, pages R151-R167.
Crossref
Crossref
Dan Tian, Natalia M. Solodin, Prashant Rajbhandari, Kelsi Bjorklund, Elaine T. Alarid & Pamela K. Kreeger. (2015) A kinetic model identifies phosphorylated estrogen receptor‐α (ERα) as a critical regulator of ERα dynamics in breast cancer. The FASEB Journal 29:5, pages 2022-2031.
Crossref
Crossref
Prashant Rajbhandari, Mary Szatkowski Ozers, Natalia M. Solodin, Christopher L. Warren & Elaine T. Alarid. (2015) Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α. Journal of Biological Chemistry 290:22, pages 13749-13762.
Crossref
Crossref
Zhong-Jian Shen & James Malter. (2015) Regulation of AU-Rich Element RNA Binding Proteins by Phosphorylation and the Prolyl Isomerase Pin1. Biomolecules 5:2, pages 412-434.
Crossref
Crossref
Jean McBryan & Leonie S. Young. 2015. Resistance to Aromatase Inhibitors in Breast Cancer. Resistance to Aromatase Inhibitors in Breast Cancer
115
144
.
P Rajbhandari, K A Schalper, N M Solodin, S J Ellison-Zelski, K Ping Lu, D L Rimm & E T Alarid. (2013) Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation. Oncogene 33:11, pages 1438-1447.
Crossref
Crossref
Wen Zhou & Joyce M. Slingerland. (2013) Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy. Nature Reviews Cancer 14:1, pages 26-38.
Crossref
Crossref
Keiichiro Okuhira, Yosuke Demizu, Takayuki Hattori, Nobumichi Ohoka, Norihito Shibata, Tomoko Nishimaki-Mogami, Haruhiro Okuda, Masaaki Kurihara & Mikihiko Naito. (2013) Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells. Cancer Science 104:11, pages 1492-1498.
Crossref
Crossref
Lu Wang, Purin Charoensuksai, Nikole J. Watson, Xing Wang, Zibo Zhao, Carlos G. Coriano, Leslie R. Kerr & Wei Xu. (2013) CARM1 automethylation is controlled at the level of alternative splicing. Nucleic Acids Research 41:14, pages 6870-6880.
Crossref
Crossref
Wei-Lan Yeh, Keiko Shioda, Kathryn R. Coser, Danielle Rivizzigno, Kristen R. McSweeney & Toshi Shioda. (2013) Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase. PLoS ONE 8:4, pages e60889.
Crossref
Crossref
Chiara Lucchetti, Isabella Caligiuri, Giuseppe Toffoli, Antonio Giordano & Flavio Rizzolio. (2013) The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer. PLoS ONE 8:2, pages e55355.
Crossref
Crossref
Akane Matsushita, Haruhiko Inoue, Shingo Goto, Akira Nakayama, Shoji Sugano, Nagao Hayashi & Hiroshi Takatsuji. (2012)
Nuclear ubiquitin proteasome degradation affects
WRKY
45 function in the rice defense program
. The Plant Journal 73:2, pages 302-313.
Crossref
Crossref
James R. Davis, Mohanad Mossalam & Carol S. Lim. (2012) Utilizing the Estrogen Receptor Ligand-Binding Domain for Controlled Protein Translocation to the Insoluble Fraction. Pharmaceutical Research 29:12, pages 3455-3463.
Crossref
Crossref
B. P. Huderson, T. T. Duplessis, C. C. Williams, H. C. Seger, C. G. Marsden, K. J. Pouey, S. M. Hill & B. G. Rowan. (2012) Stable Inhibition of Specific Estrogen Receptor α (ERα) Phosphorylation Confers Increased Growth, Migration/Invasion, and Disruption of Estradiol Signaling in MCF-7 Breast Cancer Cells. Endocrinology 153:9, pages 4144-4159.
Crossref
Crossref
Maria Marino, Marco Pellegrini, Piergiorgio La Rosa & Filippo Acconcia. (2012) Susceptibility of estrogen receptor rapid responses to xenoestrogens: Physiological outcomes. Steroids 77:10, pages 910-917.
Crossref
Crossref
Xiaomei Qi, Huiying Zhi, Adrienne Lepp, Phillip Wang, Jian Huang, Zainab Basir, Christopher R. Chitambar, Charles R. Myers & Guan Chen. (2012) p38γ Mitogen-activated Protein Kinase (MAPK) Confers Breast Cancer Hormone Sensitivity by Switching Estrogen Receptor (ER) Signaling from Classical to Nonclassical Pathway via Stimulating ER Phosphorylation and c-Jun Transcription. Journal of Biological Chemistry 287:18, pages 14681-14691.
Crossref
Crossref
Muralidharan Anbalagan, Brandy Huderson, Leigh Murphy & Brian G. Rowan. (2012) Post-Translational Modifications of Nuclear Receptors and Human Disease. Nuclear Receptor Signaling 10:1, pages nrs.10001.
Crossref
Crossref
Nibedita Gupta, Sina Grebhardt & Doris Mayer. (2012) Janus kinase 2 — A novel negative regulator of estrogen receptor α function. Cellular Signalling 24:1, pages 151-161.
Crossref
Crossref
Ana-Citlali Gradilla, Alicia Mansilla & Alberto Ferrús. (2011)
Isoform-Specific Regulation of a Steroid Hormone Nuclear Receptor by an E3 Ubiquitin Ligase in
Drosophila melanogaster
. Genetics 189:3, pages 871-883.
Crossref
Crossref
Piergiorgio La Rosa & Filippo Acconcia. (2011) Signaling functions of ubiquitin in the 17β-estradiol (E2):estrogen receptor (ER) α network. The Journal of Steroid Biochemistry and Molecular Biology 127:3-5, pages 223-230.
Crossref
Crossref
Muriel Le RomancerCoralie PoulardPascale CohenStéphanie SentisJack-Michel Renoir & Laura Corbo. (2011) Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors. Endocrine Reviews 32:5, pages 597-622.
Crossref
Crossref
Tamika T. DuplessisChristopher C. Williams, Steven M. HillBrian G. Rowan. (2011) Phosphorylation of Estrogen Receptor α at Serine 118 Directs Recruitment of Promoter Complexes and Gene-Specific Transcription. Endocrinology 152:6, pages 2517-2526.
Crossref
Crossref
Peter Kuhn, Rob Chumanov, Yidan Wang, Ying Ge, Richard R. Burgess & Wei Xu. (2011) Automethylation of CARM1 allows coupling of transcription and mRNA splicing. Nucleic Acids Research 39:7, pages 2717-2726.
Crossref
Crossref
Gianpaolo Rando, David Horner, Andrea Biserni, Balaji Ramachandran, Donatella Caruso, Paolo Ciana, Barry Komm & Adriana Maggi. (2010) An Innovative Method to Classify SERMs Based on the Dynamics of Estrogen Receptor Transcriptional Activity in Living Animals. Molecular Endocrinology 24:4, pages 735-744.
Crossref
Crossref
G L Powers, S J Ellison-Zelski, A J Casa, A V Lee & E T Alarid. (2009) Proteasome inhibition represses ERα gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer. Oncogene 29:10, pages 1509-1518.
Crossref
Crossref
Yoshiaki FUJII-KURIYAMA & Kaname KAWAJIRI. (2010) Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. Proceedings of the Japan Academy, Series B 86:1, pages 40-53.
Crossref
Crossref
Sébastien Lalevée, Christine Ferry & Cécile Rochette-Egly. 2010. Transcription Factors. Transcription Factors
251
266
.
Shivani Malik, Abhijit Shukla, Payel Sen & Sukesh R. Bhaumik. (2009) The 19 S Proteasome Subcomplex Establishes a Specific Protein Interaction Network at the Promoter for Stimulated Transcriptional Initiation in Vivo. Journal of Biological Chemistry 284:51, pages 35714-35724.
Crossref
Crossref
Gregory E. Weitsman, Wineeta Weebadda, Kanyarat Ung & Leigh C. Murphy. (2008) Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha. Breast Cancer Research and Treatment 118:2, pages 269-279.
Crossref
Crossref
Georgios Giamas, Leandro Castellano, Qin Feng, Uwe Knippschild, Jimmy Jacob, Ross S. Thomas, R. Charles Coombes, Carolyn L. Smith, Long R. Jiao & Justin Stebbing. (2009) Retracted: CK1δ modulates the transcriptional activity of ERα via AIB1 in an
estrogen-dependent manner and regulates ERα–AIB1 interactions. Nucleic Acids Research 37:9, pages 3110-3123.
Crossref
Crossref
Y. Wang, H. Zong, Y. Chi, Y. Hong, Y. Yang, W. Zou, X. Yun & J. Gu. (2009) Repression of Estrogen Receptor alpha by CDK11p58 Through Promoting its Ubiquitin-Proteasome Degradation. Journal of Biochemistry 145:3, pages 331-343.
Crossref
Crossref
Yeo Myeong Park, Jung Yoon Cho, Young Do Koo & Young Joo Lee. (2009) Effects of Inhibiting the Proteasomal Degradation of Estrogen Receptor .ALPHA. on Estrogen Receptor .ALPHA. Activation under Hypoxic Conditions. Biological and Pharmaceutical Bulletin 32:12, pages 2057-2060.
Crossref
Crossref
Akua K. Oduro, Michael K. Fritsch & Fern E. Murdoch. (2008) Chromatin context dominates estrogen regulation of pS2 gene expression. Experimental Cell Research 314:15, pages 2796-2810.
Crossref
Crossref
Tatjana A. Ishunina & Dick F. Swaab. (2008) Age-dependent ERα MB1 splice variant expression in discrete areas of the human brain. Neurobiology of Aging 29:8, pages 1177-1189.
Crossref
Crossref
Christine E. Schaub, Jason A. Gersting, Maureen Keller-Wood & Charles E. Wood. (2008) Development of ER-α and ER-β expression in the developing ovine brain and pituitary. Gene Expression Patterns 8:6, pages 457-463.
Crossref
Crossref
Xiaodong Li, Jing Huang, Brian R. Fluharty, Yanfang Huang, Stephanie L. Nott & Mesut Muyan. (2008) What are comparative studies telling us about the mechanism of ERβ action in the ERE-dependent E2 signaling pathway?. The Journal of Steroid Biochemistry and Molecular Biology 109:3-5, pages 266-272.
Crossref
Crossref
Michel Aubé, Christian Larochelle & Pierre Ayotte. (2008) 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p'-DDE) disrupts the estrogen-androgen balance regulating the growth of hormone-dependent breast cancer cells. Breast Cancer Research 10:1.
Crossref
Crossref
Jing Peng & V. Craig Jordan. 2008. Principles of Molecular Oncology. Principles of Molecular Oncology
189
206
.
Raphaël Métivier, Guillaume Huet, Rozenn Gallais, Laurence Finot, Fabien Petit, Christophe Tiffoche, Yohann Mérot, Christine LePéron, George Reid, Graziella Penot, Florence Demay, Frank Gannon, Gilles Flouriot & Gilles Salbert. 2008. Hormonal Carcinogenesis V. Hormonal Carcinogenesis V
129
138
.
Peng Yu & Thomas Kodadek. (2007) Dynamics of the Hypoxia-inducible Factor-1-Vascular Endothelial Growth Factor Promoter Complex. Journal of Biological Chemistry 282:48, pages 35035-35045.
Crossref
Crossref
Tatjana A. Ishunina, David F. Fischer & Dick F. Swaab. (2007) Estrogen receptor α and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiology of Aging 28:11, pages 1670-1681.
Crossref
Crossref
Nancy L. Weigel & Nicole L. Moore. (2007) Steroid Receptor Phosphorylation: A Key Modulator of Multiple Receptor Functions. Molecular Endocrinology 21:10, pages 2311-2319.
Crossref
Crossref
Vanessa Duong, Nathalie Boulle, Sylvain Daujat, Jérôme Chauvet, Sandrine Bonnet, Henry Neel & Vincent Cavaillès. (2007) Differential Regulation of Estrogen Receptor α Turnover and Transactivation by Mdm2 and Stress-Inducing Agents. Cancer Research 67:11, pages 5513-5521.
Crossref
Crossref
Fumiaki Ohtake, Atsushi Baba, Ichiro Takada, Maiko Okada, Kei Iwasaki, Hiromi Miki, Sayuri Takahashi, Alexander Kouzmenko, Keiko Nohara, Tomoki Chiba, Yoshiaki Fujii-Kuriyama & Shigeaki Kato. (2007) Dioxin receptor is a ligand-dependent E3 ubiquitin ligase. Nature 446:7135, pages 562-566.
Crossref
Crossref
Anders EA Dahm, Nina Iversen, Baard Birkenes, Anne Hansen Ree & Per Morten Sandset. (2006) Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1. BMC Cardiovascular Disorders 6:1.
Crossref
Crossref
Leigh C. Murphy, G.E. Weitsman, G.P. Skliris, E.M. Teh, Lin Li, B. Peng, J.R. Davie, K. Ung, Y.-L. Niu, S. Troup, L. Tomes & P.H. Watson. (2006) Potential role of estrogen receptor α (ERα) phosphorylated at Serine118 in human breast cancer in vivo. The Journal of Steroid Biochemistry and Molecular Biology 102:1-5, pages 139-146.
Crossref
Crossref
H. Faus & B. Haendler. (2006) Post-translational modifications of steroid receptors. Biomedicine & Pharmacotherapy 60:9, pages 520-528.
Crossref
Crossref
Thomas Kodadek, Devanjan Sikder & Kip Nalley. (2006) Keeping Transcriptional Activators under Control. Cell 127:2, pages 261-264.
Crossref
Crossref
Hua Zhang, Luyang Sun, Jing Liang, Wenhua Yu, Ying Zhang, Yan Wang, Yupeng Chen, Ruifang Li, Xiaojing Sun & Yongfeng Shang. (2006) The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription. The EMBO Journal 25:18, pages 4223-4233.
Crossref
Crossref
Kip Nalley, Stephen Albert Johnston & Thomas Kodadek. (2006) Proteolytic turnover of the Gal4 transcription factor is not required for function in vivo. Nature 442:7106, pages 1054-1057.
Crossref
Crossref
Raphaël Métivier, George Reid & Frank Gannon. (2006) Transcription in four dimensions: nuclear receptor‐directed initiation of gene expression. EMBO reports 7:2, pages 161-167.
Crossref
Crossref
Jing Huang, Xiaodong Li, Tao Qiao, Robert A. Bambara, Russell Hilf & Mesut Muyan. (2006) A Tale of two Estrogen Receptors (ERs): How Differential ER-Estrogen Responsive Element Interactions Contribute to Subtype-Specific Transcriptional Responses. Nuclear Receptor Signaling 4:1, pages nrs.04015.
Crossref
Crossref
Nandini Vasudevan & Donald Pfaff. (2005) Molecular mechanisms of crosstalk between thyroid hormones and estrogens. Current Opinion in Endocrinology & Diabetes 12:5, pages 381-388.
Crossref
Crossref